A Study of Bermekimab in Patients With Hidradenitis Suppurativa

Clinical trial NCT03512275 · COMPLETED

Trial details

NCT number: NCT03512275
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hidradenitis Suppurativa

Start date: 2018-06-20
Primary completion: 2019-01-14
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.